417
Views
40
CrossRef citations to date
0
Altmetric
Review Article

Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report

, , , , , , , , , , , , , , , , , , , , & show all
Pages 91-98 | Received 19 Oct 2019, Accepted 13 Feb 2020, Published online: 28 Feb 2020

References

  • Skene A. Diseases of bladder and urethra in women. New York (NY): Wm Wood; 1887.
  • Hunner GL. A rare type of bladder ulcer in women; report of cases. Boston Med Surg J. 1915;172(18):660–664.
  • Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology and treatment. Urology. 1978;12(4):381–392.
  • Wein A, Hanno P, Gillenwater J. Interstitial cystitis: an introduction to the problem. Interstitial cystitis. London: Springer-Verlag. 1990. p. 3–15.
  • Hanno P, Levin RM, Monson FC, et al. Diagnosis of Interstitial cystitis. J Urol. 1990;143(2):278–281.
  • Nordling J, Anjum F, Bade J, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004; 45(5):662–669.
  • Abrams P, Cardozo L, Fall M, et al. The standardization of terminology in lower urinary tract function. Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–178.
  • Chung MK, Butrick CW, Chung CW. Overlap of interstitial cystitis/painful bladder syndrome and overactive bladder. JSLS. 2010;14(1):83–90.
  • van de Merwe JP, Nordling J, Bouchelouche P, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–67.
  • Fall M, Baranowski AP, Fowler CJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2004;46(6):681–689.
  • Quaghebeur J, Wyndaele JJ. Bladder pain syndrome (BPS): symptom differences between type 3C BPS and non-type 3C BPS. Scand J Urol. 2015;49(4):319–320.
  • Killinger K, Boura J, Peters K. Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes? Int Urogynecol J. 2013;24(8):1295–1301.
  • Peters K, Killinger K, Mounayer M, et al. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urol. 2011;78(2):301–308.
  • Van Moh F, Vetter J, Lai HH. Comparison of urologic and non-urologic presentation in interstitial cystitis/bladder pain syndrome patients with and without Hunner lesions. Neurourol Urodyn. 2018;37(8):2911–2918.
  • Doiron RC, Tolls V, Irvine-Bird K, et al. Clinical phenotyping does not differentiate Hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol. 2016;196(4):1136–1140.
  • Braunstein R, Shapiro E, Kaye J, et al. The role of cystoscopy in the diagnosis of Hunner’s ulcer disease. J Urol. 2008;180(4):1383–1386.
  • Sairanen J, Tammela TLJ, Leppilahti M, et al. Potassium sensitivity test (PST) as a measurement of treatment efficacy of painful bladder syndrome/interstitial cystitis: a prospective study with cyclosporine A and pentosan polysulfate sodium. Neurourol Urodyn. 2007; 26(2):267–270.
  • Erickson DR, Tomaszewski JE, Kunselman AR, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008;179(5):1850–1856.
  • Logadottir Y, Ehren I, Fall M, et al. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol. 2004;171(3):1148–1151.
  • Ehrén I, Hallén Grufman K, Vrba M, et al. Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C. Scand J Urol. 2013; 47(6):503–508.
  • Vera PL, Preston DM, Moldwin RM, et al. Elevated urine levels of macrophage migration inhibitory factor in inflammatory bladder conditions: a potential biomarker for a subgroup of interstitial cystitis/bladder pain syndrome patients. Urology. 2018;116:55–62.
  • Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987;137(1):35–38.
  • Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 1990;143(6):1118–1124.
  • Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998;160(5):1663–1667.
  • Wennevik G, Meijlink J, Hanno P, et al. The role of glomerulations in bladder pain syndrome: a review. J Urol. 2016;195(1):19–25.
  • Logadottir Y, Fall M, Kåbjörn-Gustafsson C, et al. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol. 2012;46(5):365–370.
  • Aldenborg F, Fall M, Enerbäck L. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology. 1986;58(3):411–416.
  • Larsen M, Mortensen S, Nordling J, et al. Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int. 2008;102(2):204–207.
  • Peeker R, Fall M, Enerbäck L, et al. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000;163(3):1009–1015.
  • Greenberg E, Barnes R, Stewart S, et al. Transurethral resection of Hunner’s ulcers. J Urol. 1974;111(6):764–766.
  • Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J Urol. 1985;133(5):774–778.
  • Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J. 2000;11(5):290–295.
  • Payne R, O’Connor R, Kressin M, et al. Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. Can Urol Assoc J. 2013;3(6):473–477.
  • Chennamsetty A, Khourdaji I, Goike J, et al. Electrosurgical management of Hunner ulcers in a referral center’s interstitial cystitis population. Urology. 2015;85(1):74–78.
  • Schulte T, Reynolds L. Transurethral intramural injection of hydrocortone hyaluronidase for interstitial cystitis (Hunner’s ulcers). J Urol. 1956;75(1):63–65.
  • Cox M, Klutke J, Klutke C. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol. 2009;16(2):4536–4540.
  • Malloy TR, Shanberg AM. Laser therapy for interstitial cystitis. Urol Clin North Am. 1994;21(1):141–144.
  • Rofeim O, Hom D, Freid R, et al. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol. 2001;166(1):134–136.
  • Sairanen J, Tammela TL, Leppilahti M, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235–2238.
  • Fall M, Lindstrom S. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol Clin North Am. 1994;21(1):131–139.
  • Peters K, Jaeger C, Killinger K, et al. Cystectomy for ulcerative interstitial cystitis: sequelae and patients’ perceptions of improvement. Urology. 2013;82(4):829–833.
  • Rössberger J, Fall M, Jonsson O, et al. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70(4):638–642.
  • Hand JR. Interstitial cystitis: report of 223 cases (204 women and 19 men). J Urol. 1949;61(2):291–310.
  • Forrest J, Schmidt S. Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity. J Urol. 2004;172(6):2561–2562.
  • Koziol JA, Clark DC, Gittes RF, et al. The natural history of interstitial cystitis: a survey of 374 patients. J Urol. 1993;149(3):465–469.
  • Rais-Bahrami S, Friedlander J, Herati A, et al. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. BJU Int. 2012;109(9):1356–1359.
  • DeJuana C, Everett J. Interstitial cystitis: experience and review of recent literature. Urology. 1977;10(4):325–329.
  • Nickel JC, Tripp DA, Pontari M, et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol. 2010;184(4):1358–1363.
  • Abrams P, Andersson KE, Apostolidis A, et al. 6th international consultation on incontinence. Recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and fecal incontinence. Neurourol Urodynam. 2018;37(7):2271–2272.
  • Han E, Nguyen L, Sirls L, et al. Current best practice management of interstitial cystitis/bladder pain syndrome. Ther Adv Urol. 2018;10(7):197–211.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.